Market Cap 15.21M
Revenue (ttm) 170,000.00
Net Income (ttm) -16.59M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -9,758.82%
Debt to Equity Ratio 0.00
Volume 133,700
Avg Vol 125,912
Day's Range N/A - N/A
Shares Out 9.11M
Stochastic %K 1%
Beta 0.79
Analysts Hold
Price Target $4.00

Company Profile

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with range of anti-cancer regimens....

Industry: Biotechnology
Sector: Healthcare
Phone: 908 842 0100
Address:
110 Allen Road, 2nd Floor, Basking Ridge, United States
Rolo2024
Rolo2024 Jul. 26 at 12:33 AM
$LSTA No worries LSTA stock value is more than $4 once board determines the next step we should see stock value return to over $3.25. Remember we have 8 drugs in various phases of testing and approval. Earnings Report on August 6th!
0 · Reply
Defen
Defen Jul. 24 at 9:43 PM
$LSTA what a shame. They really f’d lsta and like they said can’t even sue!!
0 · Reply
Defen
Defen Jul. 24 at 9:42 PM
$LSTA wow
0 · Reply
Biotech_Pharma_Investor
Biotech_Pharma_Investor Jul. 24 at 4:34 PM
$LSTA Kuva labs destroyed them cash running out can they cloae a new deal in time??
0 · Reply
TwongStocks
TwongStocks Jul. 24 at 4:27 PM
$LSTA "There can be no assurance that the Company will be able to obtain damages from Parent or Purchaser, even to the extent legally available in any litigation that the Company may pursue, due to the Company’s limited financial resources available to fund related litigation and to Parent’s or Purchaser’s potential inability to satisfy with its existing assets any judgment that the Company might obtain."
1 · Reply
TwongStocks
TwongStocks Jul. 24 at 4:26 PM
$LSTA company terminated agreement with Kuva Labs due to inability of Kuva to secure financing. https://www.sec.gov/ix?doc=/Archives/edgar/data/0000320017/000114036126029541/ef20078724_8k.htm Kuva is obligated to pay $2M termination fee. Board of Directors will asses strategic options.
0 · Reply
Rolo2024
Rolo2024 Jul. 22 at 4:35 AM
$LSTA Now we do the limbo….. for how long?!
0 · Reply
prismmarketview
prismmarketview Jul. 21 at 4:30 PM
PRISM Mid-Day Movers: Crypto Mining and Space are Today’s Leaders. Cipher Mining Inc. (now rebranded as Cipher Digital, NASDAQ: $CIFR ) is surging today, with the stock up about 18% to 24.22 from a prior close of 20.54. Sidus Space, Inc. (NASDAQ: $SIDU ) is moving higher today, with the stock up about 16% to 2.025 from a prior close of 1.75. Other Notable Movers: Helus Pharma ( $HELP ) up 16% Bloom Energy ( $BE ) up 14% Lisata Therapeutics ( $LSTA ) down -41% https://prismmarketview.com/prism-mid-day-movers-crypto-mining-and-space-are-todays-leaders/
0 · Reply
Harunkaraca
Harunkaraca Jul. 21 at 3:55 PM
0 · Reply
dumbquestioner
dumbquestioner Jul. 21 at 3:35 PM
$LSTA Lawyers will have a field day with this one. Expect announcements of investigations by the end of the week. Why kind of firm makes an offer with no financing conditions and no financing! What is the definition of fraud?
0 · Reply
Latest News on LSTA
Lisata Therapeutics Quarterly report: Q1 2026

May 11, 2026, 4:00 PM EDT - 2 months ago

Lisata Therapeutics Quarterly report: Q1 2026


Lisata Therapeutics Annual report: Q4 2025

Mar 12, 2026, 4:00 PM EDT - 4 months ago

Lisata Therapeutics Annual report: Q4 2025


Lisata Therapeutics downgraded to Hold from Buy at Brookline

2026-01-21T14:35:15.000Z - 6 months ago

Lisata Therapeutics downgraded to Hold from Buy at Brookline


Lisata Therapeutics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:30 PM EST - 9 months ago

Lisata Therapeutics Earnings Call Transcript: Q3 2025


Lisata Therapeutics Quarterly report: Q3 2025

Nov 6, 2025, 4:30 PM EST - 9 months ago

Lisata Therapeutics Quarterly report: Q3 2025


Lisata Therapeutics Earnings release: Q3 2025

Nov 6, 2025, 4:30 PM EST - 9 months ago

Lisata Therapeutics Earnings release: Q3 2025


Lisata Therapeutics Slides: Corporate Presentation

Nov 6, 2025, 4:00 PM EST - 9 months ago

Lisata Therapeutics Slides: Corporate Presentation


Lisata Therapeutics Slides: Corporate Presentation

Oct 21, 2025, 7:00 AM EDT - 9 months ago

Lisata Therapeutics Slides: Corporate Presentation


Lisata Therapeutics to Present at LD Micro Main Event XIX

Oct 13, 2025, 8:00 AM EDT - 10 months ago

Lisata Therapeutics to Present at LD Micro Main Event XIX


Lisata Therapeutics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Lisata Therapeutics Earnings Call Transcript: Q2 2025


Lisata Therapeutics Quarterly report: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Lisata Therapeutics Quarterly report: Q2 2025


Lisata Therapeutics Earnings release: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Lisata Therapeutics Earnings release: Q2 2025


Lisata Therapeutics Earnings Call Transcript: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Lisata Therapeutics Earnings Call Transcript: Q1 2025


Lisata Therapeutics Quarterly report: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Lisata Therapeutics Quarterly report: Q1 2025


Lisata Therapeutics Earnings release: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Lisata Therapeutics Earnings release: Q1 2025


Lisata Therapeutics Slides: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Lisata Therapeutics Slides: Q1 2025


Lisata Therapeutics Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Lisata Therapeutics Proxy statement: Proxy Filing


Lisata Therapeutics Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Lisata Therapeutics Proxy statement: Proxy Filing


Lisata Therapeutics announces research license with Catalent

2025-04-15T12:11:26.000Z - 1 year ago

Lisata Therapeutics announces research license with Catalent


Lisata Therapeutics Announces Research License with Catalent

Apr 15, 2025, 8:00 AM EDT - 1 year ago

Lisata Therapeutics Announces Research License with Catalent


Lisata Therapeutics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 4:30 PM EST - 1 year ago

Lisata Therapeutics Earnings Call Transcript: Q4 2024


Lisata Therapeutics Annual report: Q4 2024

Feb 27, 2025, 4:30 PM EST - 1 year ago

Lisata Therapeutics Annual report: Q4 2024


Lisata Therapeutics Earnings release: Q4 2024

Feb 27, 2025, 4:30 PM EST - 1 year ago

Lisata Therapeutics Earnings release: Q4 2024


Lisata Therapeutics Slides: Q4 2024

Feb 27, 2025, 4:30 PM EST - 1 year ago

Lisata Therapeutics Slides: Q4 2024


Lisata Therapeutics Earnings Call Transcript: Q3 2024

Nov 12, 2024, 4:30 PM EST - 1 year ago

Lisata Therapeutics Earnings Call Transcript: Q3 2024


Lisata Therapeutics Quarterly report: Q3 2024

Nov 12, 2024, 4:30 PM EST - 1 year ago

Lisata Therapeutics Quarterly report: Q3 2024


Lisata Therapeutics Earnings release: Q3 2024

Nov 12, 2024, 4:30 PM EST - 1 year ago

Lisata Therapeutics Earnings release: Q3 2024


Lisata Therapeutics Slides: Q3 2024

Nov 12, 2024, 4:30 PM EST - 1 year ago

Lisata Therapeutics Slides: Q3 2024


Lisata Therapeutics Transcript: LD Micro Main Event XVI

Oct 29, 2024, 2:00 PM EDT - 1 year ago

Lisata Therapeutics Transcript: LD Micro Main Event XVI


Lisata Therapeutics Earnings Call Transcript: Q2 2024

Aug 12, 2024, 4:30 PM EDT - 2 years ago

Lisata Therapeutics Earnings Call Transcript: Q2 2024


Lisata Therapeutics Quarterly report: Q2 2024

Aug 12, 2024, 4:30 PM EDT - 2 years ago

Lisata Therapeutics Quarterly report: Q2 2024


Lisata Therapeutics Earnings release: Q2 2024

Aug 12, 2024, 4:30 PM EDT - 2 years ago

Lisata Therapeutics Earnings release: Q2 2024


Lisata Therapeutics Slides: Q2 2024

Aug 12, 2024, 4:30 PM EDT - 2 years ago

Lisata Therapeutics Slides: Q2 2024


Lisata Therapeutics Earnings Call Transcript: Q1 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

Lisata Therapeutics Earnings Call Transcript: Q1 2024


Lisata Therapeutics Quarterly report: Q1 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

Lisata Therapeutics Quarterly report: Q1 2024


Lisata Therapeutics Earnings release: Q1 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

Lisata Therapeutics Earnings release: Q1 2024


Lisata Therapeutics Slides: Q1 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

Lisata Therapeutics Slides: Q1 2024


Lisata Therapeutics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

Lisata Therapeutics Proxy statement: Proxy Filing


Lisata Therapeutics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

Lisata Therapeutics Proxy statement: Proxy Filing


Lisata Therapeutics Transcript: LD Micro Invitational XIV 2024

Apr 9, 2024, 10:00 AM EDT - 2 years ago

Lisata Therapeutics Transcript: LD Micro Invitational XIV 2024


Rolo2024
Rolo2024 Jul. 26 at 12:33 AM
$LSTA No worries LSTA stock value is more than $4 once board determines the next step we should see stock value return to over $3.25. Remember we have 8 drugs in various phases of testing and approval. Earnings Report on August 6th!
0 · Reply
Defen
Defen Jul. 24 at 9:43 PM
$LSTA what a shame. They really f’d lsta and like they said can’t even sue!!
0 · Reply
Defen
Defen Jul. 24 at 9:42 PM
$LSTA wow
0 · Reply
Biotech_Pharma_Investor
Biotech_Pharma_Investor Jul. 24 at 4:34 PM
$LSTA Kuva labs destroyed them cash running out can they cloae a new deal in time??
0 · Reply
TwongStocks
TwongStocks Jul. 24 at 4:27 PM
$LSTA "There can be no assurance that the Company will be able to obtain damages from Parent or Purchaser, even to the extent legally available in any litigation that the Company may pursue, due to the Company’s limited financial resources available to fund related litigation and to Parent’s or Purchaser’s potential inability to satisfy with its existing assets any judgment that the Company might obtain."
1 · Reply
TwongStocks
TwongStocks Jul. 24 at 4:26 PM
$LSTA company terminated agreement with Kuva Labs due to inability of Kuva to secure financing. https://www.sec.gov/ix?doc=/Archives/edgar/data/0000320017/000114036126029541/ef20078724_8k.htm Kuva is obligated to pay $2M termination fee. Board of Directors will asses strategic options.
0 · Reply
Rolo2024
Rolo2024 Jul. 22 at 4:35 AM
$LSTA Now we do the limbo….. for how long?!
0 · Reply
prismmarketview
prismmarketview Jul. 21 at 4:30 PM
PRISM Mid-Day Movers: Crypto Mining and Space are Today’s Leaders. Cipher Mining Inc. (now rebranded as Cipher Digital, NASDAQ: $CIFR ) is surging today, with the stock up about 18% to 24.22 from a prior close of 20.54. Sidus Space, Inc. (NASDAQ: $SIDU ) is moving higher today, with the stock up about 16% to 2.025 from a prior close of 1.75. Other Notable Movers: Helus Pharma ( $HELP ) up 16% Bloom Energy ( $BE ) up 14% Lisata Therapeutics ( $LSTA ) down -41% https://prismmarketview.com/prism-mid-day-movers-crypto-mining-and-space-are-todays-leaders/
0 · Reply
Harunkaraca
Harunkaraca Jul. 21 at 3:55 PM
0 · Reply
dumbquestioner
dumbquestioner Jul. 21 at 3:35 PM
$LSTA Lawyers will have a field day with this one. Expect announcements of investigations by the end of the week. Why kind of firm makes an offer with no financing conditions and no financing! What is the definition of fraud?
0 · Reply
Golferhack12
Golferhack12 Jul. 21 at 3:10 PM
$LSTA the question is does the stock go lower from here or what's the outcome in the next days or weeks
0 · Reply
prohibited
prohibited Jul. 21 at 2:49 PM
$LSTA old news but valid😀
0 · Reply
SQUEAKSBANDIT
SQUEAKSBANDIT Jul. 21 at 1:18 PM
$LSTA sorry to all those taking a hit here this outfit seemed scammy as CLBS back in the day now what happens? toxic financing/reverse split black hole? find a reverse merger partner likely at a lower valuation than todays price? hope kuva comes back to the table with an LOC from their local credit union? IDK if i held shares here i'd strongly consider selling through my inventory and never looking back GLA
0 · Reply
stockanalysis_
stockanalysis_ Jul. 21 at 1:04 PM
Premarket Losers: $CLBK $LBGJ $ZYBT $LSTA $CDTG Download this screener: https://stockanalysis.com/markets/premarket/losers/?ref=saveontrading
0 · Reply
TwongStocks
TwongStocks Jul. 21 at 11:22 AM
$LSTA Latest update https://www.sec.gov/Archives/edgar/data/320017/000114036126029022/0001140361-26-029022-index.htm • Tender offer expired one minute after 11:59pm ET on July 20, 2026. 66.8% of shares have been tendered. • Company (LSTA) informed Parent (Kuva) that all of the conditions to the Offer have been satisfied. Kuva is obligated to close the offer and pay for all shares. •HOWEVER, Kuva is unable to obtain sufficient financing to fund the Offer as of the expiration time. As a result, Kuva has not accepted the tendered sahres & has not indicated when they will be able to do so. • LSTA is evaluating its rights and remedies in the event Kuva is not able to close the offer.
0 · Reply
Rolo2024
Rolo2024 Jul. 19 at 9:34 PM
$LSTA Just send my money I have more investments to attend to this week! :)
1 · Reply
focafoca99
focafoca99 Jul. 17 at 11:13 AM
$LSTA extended its merger deadline to July 21, 2026.
0 · Reply
TwongStocks
TwongStocks Jul. 17 at 11:01 AM
$LSTA Under the terms of the agreement, the tender offer is supposed to close as long as Kuva gets more than a majority of shares tendered. This morning's filing reports over 64% of shares have been tendered. This is crazy. I have never seen a tender offer extended this many times when more than 50% of shares have been validly tendered. It's wild that Kuva still needs more time to secure enough financing to purchase all the shares.
0 · Reply
TwongStocks
TwongStocks Jul. 17 at 10:44 AM
$LSTA ANOTHER extension. https://www.sec.gov/Archives/edgar/data/320017/000114036126028733/ny20077391x2_sctota.htm Tender offer is extended until 11:59pm July 20. Outside date extended to July 21.
0 · Reply
STACKD0E
STACKD0E Jul. 13 at 6:16 PM
0 · Reply
TwongStocks
TwongStocks Jul. 10 at 10:22 PM
$LSTA Tender offer extended to July 16 despite the fact that 56% of shares have been validly tendered. https://www.sec.gov/Archives/edgar/data/320017/000114036126028238/ny20077391x1_sctota.htm
1 · Reply
jembo
jembo Jul. 9 at 3:17 PM
$LSTA I will be tendering my shares today. I do not see a better offer coming within the time allowed by the current cash burn rate. My best estimate is if this TO fails, bankruptcy is next within one year or less. Based upon the information I have gathered, I anticipate the TO closing by the Aug. 17th extended outside date. Please do your own research, there are multiple resources to contact to gather information and make an informed decision.
0 · Reply